GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Europe AG (OTCPK:CAKFY) » Definitions » Cash Conversion Cycle

McKesson Europe AG (McKesson Europe AG) Cash Conversion Cycle : 3.14 (As of Mar. 2022)


View and export this data going back to 2008. Start your Free Trial

What is McKesson Europe AG Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

McKesson Europe AG's Days Sales Outstanding for the six months ended in Mar. 2022 was 58.46.
McKesson Europe AG's Days Inventory for the six months ended in Mar. 2022 was 41.75.
McKesson Europe AG's Days Payable for the six months ended in Mar. 2022 was 97.07.
Therefore, McKesson Europe AG's Cash Conversion Cycle (CCC) for the six months ended in Mar. 2022 was 3.14.


McKesson Europe AG Cash Conversion Cycle Historical Data

The historical data trend for McKesson Europe AG's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Europe AG Cash Conversion Cycle Chart

McKesson Europe AG Annual Data
Trend Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.47 17.91 7.47 2.39 3.14

McKesson Europe AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.47 17.91 7.47 2.39 3.14

Competitive Comparison of McKesson Europe AG's Cash Conversion Cycle

For the Medical Distribution subindustry, McKesson Europe AG's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


McKesson Europe AG's Cash Conversion Cycle Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, McKesson Europe AG's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where McKesson Europe AG's Cash Conversion Cycle falls into.



McKesson Europe AG Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

McKesson Europe AG's Cash Conversion Cycle for the fiscal year that ended in Mar. 2022 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=58.46+41.75-97.07
=3.14

McKesson Europe AG's Cash Conversion Cycle for the quarter that ended in Mar. 2022 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=58.46+41.75-97.07
=3.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


McKesson Europe AG  (OTCPK:CAKFY) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


McKesson Europe AG Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of McKesson Europe AG's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


McKesson Europe AG (McKesson Europe AG) Business Description

Traded in Other Exchanges
N/A
Address
Stockholmer Platz 1, Stuttgart, BW, DEU, 70137
McKesson Europe AG is a medical care company that provides logistics and services to the pharmaceutical and healthcare sectors. The company operates two distinct segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution business sells wholesale pharmaceutical products and generates the majority of the company's revenue. The Retail Pharmacy segment operates its own pharmacies in addition to franchise pharmacies that provide prescriptions and over-the-counter pharmaceutical products. Geographically, the company's revenue derives predominantly from the United Kingdom, France, Germany, and other countries.

McKesson Europe AG (McKesson Europe AG) Headlines

No Headlines